365 related articles for article (PubMed ID: 34068834)
1. Incorporation of Antibiotics into Solid Lipid Nanoparticles: A Promising Approach to Reduce Antibiotic Resistance Emergence.
Arana L; Gallego L; Alkorta I
Nanomaterials (Basel); 2021 May; 11(5):. PubMed ID: 34068834
[TBL] [Abstract][Full Text] [Related]
2. Antibiotic resistant bacteria: current situation and treatment options to accelerate the development of a new antimicrobial arsenal.
Tarín-Pelló A; Suay-García B; Pérez-Gracia MT
Expert Rev Anti Infect Ther; 2022 Aug; 20(8):1095-1108. PubMed ID: 35576494
[TBL] [Abstract][Full Text] [Related]
3. Nano-fats for bugs: the benefits of lipid nanoparticles for antimicrobial therapy.
Thorn CR; Thomas N; Boyd BJ; Prestidge CA
Drug Deliv Transl Res; 2021 Aug; 11(4):1598-1624. PubMed ID: 33675007
[TBL] [Abstract][Full Text] [Related]
4. Coping with antibiotic resistance: combining nanoparticles with antibiotics and other antimicrobial agents.
Allahverdiyev AM; Kon KV; Abamor ES; Bagirova M; Rafailovich M
Expert Rev Anti Infect Ther; 2011 Nov; 9(11):1035-52. PubMed ID: 22029522
[TBL] [Abstract][Full Text] [Related]
5. Lipid Nanocarriers-Enabled Delivery of Antibiotics and Antimicrobial Adjuvants to Overcome Bacterial Biofilms.
Ahsan A; Thomas N; Barnes TJ; Subramaniam S; Loh TC; Joyce P; Prestidge CA
Pharmaceutics; 2024 Mar; 16(3):. PubMed ID: 38543290
[TBL] [Abstract][Full Text] [Related]
6. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
7. Liposomes as Antibiotic Delivery Systems: A Promising Nanotechnological Strategy against Antimicrobial Resistance.
Ferreira M; Ogren M; Dias JNR; Silva M; Gil S; Tavares L; Aires-da-Silva F; Gaspar MM; Aguiar SI
Molecules; 2021 Apr; 26(7):. PubMed ID: 33918529
[TBL] [Abstract][Full Text] [Related]
8. Recent Advances in Antimicrobial Nano-Drug Delivery Systems.
Zong TX; Silveira AP; Morais JAV; Sampaio MC; Muehlmann LA; Zhang J; Jiang CS; Liu SK
Nanomaterials (Basel); 2022 May; 12(11):. PubMed ID: 35683711
[TBL] [Abstract][Full Text] [Related]
9. Solid lipid nanoparticles and nanostructured lipid carriers as novel drug delivery systems: applications, advantages and disadvantages.
Ghasemiyeh P; Mohammadi-Samani S
Res Pharm Sci; 2018 Aug; 13(4):288-303. PubMed ID: 30065762
[TBL] [Abstract][Full Text] [Related]
10. Lipid and polymer nanoparticles for drug delivery to bacterial biofilms.
Forier K; Raemdonck K; De Smedt SC; Demeester J; Coenye T; Braeckmans K
J Control Release; 2014 Sep; 190():607-23. PubMed ID: 24794896
[TBL] [Abstract][Full Text] [Related]
11. Solid lipid nanoparticles carrying Eugenia caryophyllata essential oil: the novel nanoparticulate systems with broad-spectrum antimicrobial activity.
Fazly Bazzaz BS; Khameneh B; Namazi N; Iranshahi M; Davoodi D; Golmohammadzadeh S
Lett Appl Microbiol; 2018 Jun; 66(6):506-513. PubMed ID: 29569372
[TBL] [Abstract][Full Text] [Related]
12. Nanotechnology as a Novel Approach in Combating Microbes Providing an Alternative to Antibiotics.
Mubeen B; Ansar AN; Rasool R; Ullah I; Imam SS; Alshehri S; Ghoneim MM; Alzarea SI; Nadeem MS; Kazmi I
Antibiotics (Basel); 2021 Nov; 10(12):. PubMed ID: 34943685
[TBL] [Abstract][Full Text] [Related]
13. Nanoengineered drug delivery systems for enhancing antibiotic therapy.
Kalhapure RS; Suleman N; Mocktar C; Seedat N; Govender T
J Pharm Sci; 2015 Mar; 104(3):872-905. PubMed ID: 25546108
[TBL] [Abstract][Full Text] [Related]
14. Application of Solid Lipid Nanoparticles to Improve the Efficiency of Anticancer Drugs.
Bayón-Cordero L; Alkorta I; Arana L
Nanomaterials (Basel); 2019 Mar; 9(3):. PubMed ID: 30909401
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial hydrogels: a new weapon in the arsenal against multidrug-resistant infections.
Ng VW; Chan JM; Sardon H; Ono RJ; García JM; Yang YY; Hedrick JL
Adv Drug Deliv Rev; 2014 Nov; 78():46-62. PubMed ID: 25450263
[TBL] [Abstract][Full Text] [Related]
16. Antibiotic-loaded lipid-based nanocarrier: A promising strategy to overcome bacterial infection.
Bazán Henostroza MA; Diniz Tavares G; Nishitani Yukuyama M; De Souza A; José Barbosa E; Carlos Avino V; Dos Santos Neto E; Rebello Lourenço F; Löbenberg R; Araci Bou-Chacra N
Int J Pharm; 2022 Jun; 621():121782. PubMed ID: 35489605
[TBL] [Abstract][Full Text] [Related]
17. Tackling Threats and Future Problems of Multidrug-Resistant Bacteria.
Medina E; Pieper DH
Curr Top Microbiol Immunol; 2016; 398():3-33. PubMed ID: 27406189
[TBL] [Abstract][Full Text] [Related]
18. Imipenem/cilastatin encapsulated polymeric nanoparticles for destroying carbapenem-resistant bacterial isolates.
Shaaban MI; Shaker MA; Mady FM
J Nanobiotechnology; 2017 Apr; 15(1):29. PubMed ID: 28399890
[TBL] [Abstract][Full Text] [Related]
19. Nanoparticles incorporated hydrogels for delivery of antimicrobial agents: developments and trends.
Ahmad N; Bukhari SNA; Hussain MA; Ejaz H; Munir MU; Amjad MW
RSC Adv; 2024 Apr; 14(19):13535-13564. PubMed ID: 38665493
[TBL] [Abstract][Full Text] [Related]
20. Overcoming Multidrug Resistance of Antibiotics via Nanodelivery Systems.
Imran M; Jha SK; Hasan N; Insaf A; Shrestha J; Shrestha J; Devkota HP; Khan S; Panth N; Warkiani ME; Dua K; Hansbro PM; Paudel KR; Mohammed Y
Pharmaceutics; 2022 Mar; 14(3):. PubMed ID: 35335962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
